Literature DB >> 11192539

N-acetyl-L-cysteine inhibits bleomycin-induced interleukin-8 secretion by bronchial epithelial cells.

Y Gon1, S Hashimoto, T Nakayama, K Matsumoto, T Koura, I Takeshita, T Horie.   

Abstract

OBJECTIVE: Bleomycin (BLM) has proven effective for the treatment of cancers, but the most serious dose-limiting side-effect is the development of pulmonary toxicity. Although the precise mechanism in the pathogenesis of BLM-induced lung injury has not been determined, oxygen radicals and neutrophils are indicated to play a key role in it. Interleukin-8 (IL-8) is thought to be an important mediator of the pathogenesis of acute lung injury.
METHODOLOGY: The IL-8 production from bronchial epithelial cell line, BEAS-2B cells was measured by enzyme-linked immunosorbent assays for IL-8.
RESULTS: The concentrations of IL-8 were reportedly elevated in BLM-induced lung injury, suggesting the involvement of IL-8 in the pathogenesis of BLM-induced lung injury. In the present study, we showed that BLM induced the expression of IL-8 protein and mRNA in BEAS-2B cells, and N-acetyl-L-cysteine (NAC) inhibited IL-8 expression. In addition, the structurally unrelated antioxidant, pyrrolidine dithiocarbamate (PDTC) also effectively inhibited BLM-induced IL-8 production.
CONCLUSION: These results suggest that anti-oxidant-sensitive mechanism might be involved in the inhibition of IL-8 secretion by BLM-stimulated bronchial epithelial cells and that NAC might be useful for the treatment of BLM-induced lung injury.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11192539

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  6 in total

1.  Colon cancer survival with herbal medicine and vitamins combined with standard therapy in a whole-systems approach: ten-year follow-up data analyzed with marginal structural models and propensity score methods.

Authors:  Michael McCulloch; Michael Broffman; Mark van der Laan; Alan Hubbard; Lawrence Kushi; Donald I Abrams; Jin Gao; John M Colford
Journal:  Integr Cancer Ther       Date:  2011-09-30       Impact factor: 3.279

2.  In situ assessment of oxidant and nitrogenic stress in bleomycin pulmonary fibrosis.

Authors:  Simona Inghilleri; Patrizia Morbini; Tiberio Oggionni; Sergio Barni; Carla Fenoglio
Journal:  Histochem Cell Biol       Date:  2005-11-24       Impact factor: 4.304

3.  In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats.

Authors:  A Serrano-Mollar; D Closa; N Prats; S Blesa; M Martinez-Losa; J Cortijo; J M Estrela; E J Morcillo; O Bulbena
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

4.  Induction of CXCL5 during inflammation in the rodent lung involves activation of alveolar epithelium.

Authors:  Samithamby Jeyaseelan; Rizwan Manzer; Scott K Young; Masahiro Yamamoto; Shizuo Akira; Robert J Mason; G Scott Worthen
Journal:  Am J Respir Cell Mol Biol       Date:  2005-03-18       Impact factor: 6.914

5.  Protective and therapeutic effect of apocynin on bleomycin-induced lung fibrosis in rats.

Authors:  Talat Kilic; Hakan Parlakpinar; Elif Taslidere; Sedat Yildiz; Alaadin Polat; Nigar Vardi; Cemil Colak; Hilal Ermis
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

Review 6.  Possible Treatment Approaches of Sulfur Mustard-Induced Lung Disorders, Experimental and Clinical Evidence, an Updated Review.

Authors:  Mohammad Reza Khazdair; Mohammad Hossein Boskabady
Journal:  Front Med (Lausanne)       Date:  2022-04-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.